Medications After a Suicide Attempt
For patients after a suicide attempt, start cognitive behavioral therapy-based psychotherapy as the primary intervention, and consider ketamine infusion as adjunctive treatment for acute suicidal ideation in those with major depressive disorder, or clozapine for patients with schizophrenia/schizoaffective disorder who have ongoing suicidal ideation or prior attempts.
Primary Treatment Framework
The 2024 VA/DoD guidelines provide the most current evidence-based approach 1. The strongest recommendation is for CBT-based psychotherapy focused on suicide prevention (strong recommendation) for patients with suicidal behavior in the past 6 months 1. This should be your first-line intervention, not medication.
Medication Considerations by Clinical Context
For Acute Suicidal Ideation with Major Depressive Disorder
- Ketamine infusion is suggested as adjunctive treatment for short-term reduction in suicidal ideation 1
- This provides rapid relief (within hours to days) compared to traditional antidepressants which take weeks 2
- Important caveat: There is insufficient evidence that ketamine reduces actual suicide attempts or completed suicide 1
For Schizophrenia or Schizoaffective Disorder
- Clozapine is recommended to reduce suicide attempt risk in patients with ongoing suicidal ideation or history of attempts 1
- This is the only FDA-approved medication specifically for reducing recurrent suicidal behavior 2
For Mood Disorders (Bipolar/Unipolar Depression)
- Lithium has insufficient evidence despite historical use - the guidelines shifted from weak support to insufficient evidence 1
- Traditional antidepressants show complex patterns: 50% of patients presenting with suicidal ideation were already on antidepressants, with a spike in new prescriptions the month before ED presentation 3
Critical Safety Considerations
Avoid prescribing medications that are lethal in overdose:
- Minimize or eliminate tricyclic antidepressants - these were decreased post-ED presentation in real-world practice 3
- Reduce opioid prescriptions (though 21% still received them post-attempt, which is problematic) 3
- Benzodiazepines and opioids are the most frequently used in suicide attempts 4
Medications associated with increased suicidal ideation reports include:
- Alprazolam, zolpidem, amphetamine, quetiapine, and fluoxetine showed highest reporting odds ratios 5
- Exercise particular caution in patients under age 21, where antidepressants show age-related acute worsening of suicidal ideation 2
Post-Discharge Management Algorithm
Immediate (First Week):
First Month:
Ongoing:
What NOT to Do
- Do not rely on risk stratification tools alone - insufficient evidence supports any specific tool 1
- Do not assume safety planning alone is sufficient - insufficient evidence it reduces attempts 1
- Do not prescribe dialectical behavior therapy expecting suicide reduction - insufficient evidence despite popularity 1
- Do not use repetitive transcranial magnetic stimulation for suicide risk reduction - insufficient evidence 1
The Evidence Hierarchy
The 2025 VA/DoD guidelines 1 represent the highest quality, most recent evidence and should guide all decisions. Notably, psychotherapy receives stronger recommendations than any medication except in specific diagnostic contexts (schizophrenia for clozapine, MDD with acute SI for ketamine). The shift away from lithium recommendations and the cautious stance on commonly used interventions like safety planning reflects the evolving and often disappointing evidence base for suicide prevention interventions.